What’s happening in our world?
As a global medical consultancy, our team of experts are dedicated to sharing their expertise and knowledge, to bring excellence to the development and use of pharmaceuticals, for the advancement of human health.
May 17, 2021
On miners and bots – the future of the Medical Affairs Department
On miners and bots – the future of the Medical Affairs DepartmentIt’s 2025 and I would like you to join me in welcoming the new colleagues to the Medical Affairs Department:A data scientist, an AI bot and a digital capabilities specialist. Who are they and how could they enhance the work a Medical Affairs team…
March 8, 2021
The role of radiopharmaceuticals in the diagnosis and treatment of cancer
Clinical Development Team Radiopharmaceuticals are radioisotopes that have been bound to biological molecules to target specific cells, organs or tissues. These relatively new drugs are being increasingly used for both the diagnosis and treatment of a number of diseases including: prostate cancer, renal cancer and glioblastoma. These medicines may allow for better diagnosis and more…
February 22, 2021
A Vision for Bio-Tech Beyond COVID-19
Clinical Development Team A revealing final session of the “AusBiotech and Invest 2020” conference addressed the opportunities and risks for the Australian Biotechnology sector. A discussion between diverse industry experts painted an optimistic future for the industry as recent government policy movements have provided a golden opportunity for Australian Biotech to showcase its value. It…
February 9, 2021
The role of digital health in clinical trials
The role of digital health in clinical trials Rose-Marie Pennisi – Pharmaceutical Manager Digital tools and technologies are transforming the way clinical trials are being conducted and creating better engagement with more empowered trial participants and better collaboration between trial sites, clinicians, vendors and sponsors. Not only can these new innovative electronic tools and platforms improve…
January 25, 2021
The Real World Evidence Revolution – What’s the hype all about?
Rose-Marie Pennisi – Pharmaceutical Manager With the costs of new product development now estimated to be around $1.4 billion USD, Real World Evidence (RWE) is more important than ever with companies looking for ways to do more with less. RWE) is emerging as invaluable in the clinical evidence landscape and transforming the way we collect clinical…
November 21, 2018
My Medical Department was delighted to host a booth at this year’s AusBiotech Exhibition in Brisbane (31st October – 2nd November).
As Australia’s premier life science conference, AusBiotech brings together all levels of industry to establish and develop client relationships, network with like-minded service providers and build awareness of their unique customer value proposition within the international life sciences community. At this year’s event, My Medical Department had the privilege to connect with many remarkable Australian…
August 21, 2018
Is your product a medicine, device, cosmetic or food? Know how to tell.
Many products make claims about their health effects. This does not necessarily mean that they are therapeutic goods. However, the desire to extract more health benefits from our cosmetics and foods has made it hard to tell and raises the question: what is my product? Depending on its use, it’s important to decide the intended…
July 20, 2018
Digital Medical Information – Are you online?
We live in a digital world. It has reshaped society and the way we interact so why hasn’t it re-shaped the pharmaceutical industry? Hiding behind the challenges of interacting digitally and treating it like an optional add-on, the pharmaceutical industry has fallen behind in a world that’s embraced a’ digital-first’ approach. Communications of all types…
July 20, 2018
My Medical Department recently exhibited at the Drug Information Association (DIA) in Boston, June 24-28th.
DIA brings together life sciences professionals from across all areas of expertise to engage with patients, industry, academic and clinical thought leaders and pharmaceutical industry stakeholders, providing an unrivalled platform to promote the benefits of conducting clinical research activities in Australia to a global audience. We engaged with global decision-makers and influencers in the biotechnology hub of 2018…